Randomized Clinical Trial of First-Line Genome Sequencing in Pediatric White Matter Disorders.

Saved in:
Bibliographic Details
Title: Randomized Clinical Trial of First-Line Genome Sequencing in Pediatric White Matter Disorders.
Authors: Vanderver A; Division of Neurology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Bernard G; Departments of Neurology and Neurosurgery, Pediatrics, and Human Genetics, McGill University, Montreal, Quebec, Canada.; Department of Specialized Medicine, Division of Medical Genetics, Montreal Children's Hospital and McGill University Health Centre, Montreal, Quebec, Canada.; Child Health and Human Development Program, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada., Helman G; Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland, Australia.; Murdoch Children's Research Institute, Royal Children's Hospital, Melbourne, Victoria, Australia., Sherbini O; Division of Neurology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Boeck R; Child Neurology Consultants of Austin, Austin, Texas, USA.; University of Texas at Austin Dell Medical School, Austin, Texas, USA., Cohn J; Family Medicine, Broadlands Family Practice at Ashburn, Ashburn, Virginia, USA., Collins A; Department of Neurology, Anschutz Medical Campus, University of Colorado School of Medicine, Aurora, Colorado, USA., Demarest S; Department of Neurology, Anschutz Medical Campus, University of Colorado School of Medicine, Aurora, Colorado, USA., Dobbins K; Walter Reed National Military Medical Center, Bethesda, Maryland, USA., Emrick L; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA., Fraser JL; Division of Genetics and Metabolism, Rare Disease Institute, Children's National Hospital, Washington, District of Columbia, USA.; George Washington University, Washington, District of Columbia, USA., Masser-Frye D; Rady Children's Hospital, San Diego, California, USA., Hayward J; Department of Pediatrics, Kaiser Oakland, Oakland, California, USA., Karmarkar S; Department of Neurology, Le Bonheur Children's Hospital, Memphis, Tennessee, USA.; Department of Pediatrics, University of Tennessee Health Science Center, Memphis, Tennessee, USA., Keller S; Division of Neurology, Department of Pediatrics, Emory University, Atlanta, Georgia, USA., Mirrop S; Pediatric Associates of Austin, Austin, Texas, USA., Mitchell W; Division of Neurology, Children's Hospital of Los Angeles, Los Angeles, California, USA.; Keck School of Medicine, University of Southern California, Los Angeles, California, USA., Pathak S; Clinical Neurology, Washington University Clinical Associates, St Louis, Missouri, USA.; Department of Neurology, Washington University School of Medicine, St Louis, Missouri, USA., Sherr E; Department of Neurology, University of California, San Francisco School of Medicine, San Francisco, California, USA., van Haren K; Department of Neurology, Stanford University Medical Center, Stanford, California, USA., Waters E; Pediatric Associates of Stockton, Stockton, California, USA., Wilson JL; Division of Pediatric Neurology, Oregon Health & Science University School of Medicine, Portland, Oregon, USA., Zhorne L; Stead Family Department of Pediatrics, Carver College of Medicine, University of Iowa Health Care, Iowa City, Iowa, USA., Schiffmann R; Institute of Metabolic Disease, Baylor Scott & White Research Institute, Dallas, Texas, USA., van der Knaap MS; Department of Child Neurology, VU University Medical Center, Amsterdam, the Netherlands.; Department of Functional Genomics, Amsterdam Neuroscience, VU University, Amsterdam, the Netherlands., Pizzino A; Division of Neurology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Dubbs H; Division of Neurology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Shults J; Department of Biostatistics, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Simons C; Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland, Australia.; Murdoch Children's Research Institute, Royal Children's Hospital, Melbourne, Victoria, Australia., Taft RJ; Illumina, San Diego, California, USA.
Corporate Authors: LeukoSEQ Workgroup
Source: Annals of neurology [Ann Neurol] 2020 Aug; Vol. 88 (2), pp. 264-273. Date of Electronic Publication: 2020 Jun 09.
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 7707449 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1531-8249 (Electronic) Linking ISSN: 03645134 NLM ISO Abbreviation: Ann Neurol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1531-8249
DOI:10.1002/ana.25757